LA enhances Tacrolimus efficacy Supplementation Exerts a Synergistic Effect on Tacrolimus Efficacy by Modulating Th17/Treg Balance in Lupus-Prone Mice the SIGNR3 Pathway.
High relevance for autoimmune studies
We investigated the effects of combining lactic acid (LA) with Tacrolimus (Tac) on treating lupus in mice. By administering both treatments, we observed an improvement in gut health and a balanced ratio of T cell subsets.
The combination therapy significantly decreased harmful autoantibody levels and improved kidney health. Additionally, it boosted regulatory T (Treg) cells while reducing T helper 17 (Th17) cells, ultimately enhancing the effectiveness of Tac for managing lupus-like conditions.
Read More
We assessed how Lactobacillus casei, a type of probiotic bacteria, impacted autoimmune responses in rats with rheumatoid arthritis. The treatment showed promise, significantly reducing joint swelling and preventing bone destruction by restoring the gut microbiome.
The analysis revealed that L. casei not only helped correct microbiome imbalances but also lowered inflammation indicators. Though these results are promising, further investigation is needed to confirm the effectiveness of probiotics in human arthritis treatment.
Read More
Synbiotics improve rheumatoid arthritis outcomesSynbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial.
High relevance for autoimmune therapies.
We examined how synbiotic supplementation impacts patients with rheumatoid arthritis over 8 weeks. In our double-blind, placebo-controlled trial involving 54 participants, we found that those taking synbiotics experienced significant improvements. These included lower inflammation markers such as hs-CRP and better joint pain scores on the DAS-28 and VAS.
Additionally, improvements were noted in insulin resistance and oxidative stress markers, hinting at potential metabolic benefits. Overall, our findings suggest that synbiotic treatment could play a role in managing some aspects of rheumatoid arthritis effectively.
Read More
We examined how a special probiotic mix, known as IRT5, affects autoimmune diabetes in non-obese diabetic (NOD) mice. Administered frequently over 36 weeks, this combination not only reduced diabetes incidence but also lowered insulitis scores and increased insulin-producing β-cell mass.
Additionally, IRT5 improved gut health and changed the makeup of immune cells in the pancreas and intestines. While some immune responses stayed the same, the shift towards more gut-focused regulatory T cells suggests it could be a promising treatment for type 1 diabetes.
Read More
Synbiotics improve rheumatoid arthritis symptomsSynbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial.
High relevance; significant findings
We investigated how synbiotic supplementation affects patients with rheumatoid arthritis (RA). In an 8-week, randomized, double-blind trial involving 54 participants, we compared the outcomes of those taking synbiotic capsules with a placebo group.
After the trial, those who received synbiotics showed a significant drop in inflammation markers and pain levels. Additionally, improvements were observed in insulin resistance and overall metabolic responses.
These findings suggest that synbiotics might benefit individuals managing RA by reducing inflammation and enhancing metabolic health.
Read More